141 related articles for article (PubMed ID: 2371923)
41. Stress-induced potentiation of morphine-induced analgesia in morphine-tolerant rats.
Fleetwood SW; Holtzman SG
Neuropharmacology; 1989 Jun; 28(6):563-7. PubMed ID: 2569174
[TBL] [Abstract][Full Text] [Related]
42. A selective role for brain histamine in prolactin release induced by opiates.
Netti C; Guidobono F; Sibilia V; Pagani F; Villa I; Pecile A
Agents Actions; 1990 Apr; 30(1-2):223-5. PubMed ID: 2142564
[TBL] [Abstract][Full Text] [Related]
43. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
44. μ-Opioid and N-methyl-D-aspartate receptors in the amygdala contribute to minocycline-induced potentiation of morphine analgesia in rats.
Ghazvini H; Rezayof A; Ghasemzadeh Z; Zarrindast MR
Behav Pharmacol; 2015 Jun; 26(4):383-92. PubMed ID: 25563202
[TBL] [Abstract][Full Text] [Related]
45. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
46. Opioid receptors mediating antinociception from beta-endorphin and morphine in the periaqueductal gray.
Smith DJ; Robertson B; Monroe PJ; Taylor DA; Leedham JA; Cabral JD
Neuropharmacology; 1992 Nov; 31(11):1137-50. PubMed ID: 1335557
[TBL] [Abstract][Full Text] [Related]
47. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats.
Mitchell JM; Lowe D; Fields HL
Neuroscience; 1998 Nov; 87(1):123-33. PubMed ID: 9722146
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological profile of the potentiation of opioid analgesia by restraint stress.
Calcagnetti DJ; Fleetwood SW; Holtzman SG
Pharmacol Biochem Behav; 1990 Sep; 37(1):193-9. PubMed ID: 2175919
[TBL] [Abstract][Full Text] [Related]
49. A study of the analgesic interaction between intrathecal morphine and subcutaneous nalbuphine in the rat.
Loomis CW; Penning J; Milne B
Anesthesiology; 1989 Nov; 71(5):704-10. PubMed ID: 2817464
[TBL] [Abstract][Full Text] [Related]
50. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
Gmerek DE; Cowan A; Woods JH
J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
[TBL] [Abstract][Full Text] [Related]
51. Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice.
Funada M; Suzuki T; Narita M; Misawa M; Nagase H
Brain Res; 1993 Aug; 619(1-2):163-72. PubMed ID: 8374774
[TBL] [Abstract][Full Text] [Related]
52. An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
Chen XH; Adams JU; Geller EB; DeRiel JK; Adler MW; Liu-Chen LY
Eur J Pharmacol; 1995 Feb; 275(1):105-8. PubMed ID: 7774656
[TBL] [Abstract][Full Text] [Related]
53. Involvement of brain histamine in basal and stress-induced release of prolactin in the rat.
Netti C; Guidobono F; Sibilia V; Villa I; Cazzamalli E; Pecile A
Agents Actions; 1987 Apr; 20(3-4):236-8. PubMed ID: 3604804
[TBL] [Abstract][Full Text] [Related]
54. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
Suh HW; Chung KM; Kim YH; Huh SO; Song DK
Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
[TBL] [Abstract][Full Text] [Related]
55. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
DeLander GE; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1984 Oct; 231(1):91-6. PubMed ID: 6092607
[TBL] [Abstract][Full Text] [Related]
56. Hepatobiliary effects of morphine are mediated in the brain.
Hurwitz A; Looney G; Sullins M; Ben-Zvi Z
Hepatology; 1990 Dec; 12(6):1406-12. PubMed ID: 2175293
[TBL] [Abstract][Full Text] [Related]
57. Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat.
Koenig JI; Mayfield MA; McCann SM; Krulich L
Life Sci; 1984 May; 34(19):1829-37. PubMed ID: 6330479
[TBL] [Abstract][Full Text] [Related]
58. Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice.
Menendez L; Andres-Trelles F; Hidalgo A; Baamonde A
Brain Res; 1993 May; 611(2):264-71. PubMed ID: 8392894
[TBL] [Abstract][Full Text] [Related]
59. A single restraint stress exposure potentiates analgesia induced by intrathecally administered DAGO.
Calcagnetti DJ; Stafinsky JL; Crisp T
Brain Res; 1992 Oct; 592(1-2):305-9. PubMed ID: 1450919
[TBL] [Abstract][Full Text] [Related]
60. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
McNally GP; Westbrook RF
Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
